| Authors: |
Jolly RA; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA. Electronic address: jolly_robert_a@lilly.com., Trejo-Martin A; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA., Bercu JP; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA., Powley MW; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Tennant RE; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK., Ponting DJ; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK., Nudelman R; Nudelman ChemTox Consulting Ltd.15 Miller St, Rehovot, 7628422, Israel., Sobol Z; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Czich A; Sanofi, R&D Translational Medicine Preclinical Safety, D-69526, Frankfurt, DE, Germany., Johnson GE; Swansea University Medical School, Swansea University, Swansea, Wales, UK., Yang Y; AbbVie Inc., Global Preclinical Safety, North Chicago, IL, 60064, USA., Kobets T; New York Medical College, Department of Pathology, Microbiology and Immunology, Valhalla, NY, 10595, USA., White PA; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, CA, USA., Minocherhomji S; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA., Lynch AM; GSK, Genetic and Investigative Toxicology, Stevenage, Herts, SG1 2NY, UK., Zeller A; Pharmaceutical Sciences, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Ott GR; Teva Pharmaceuticals, West Chester, PA, 19380, USA., Escobar PA; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Hobbs C; Inotiv, Rockville, MD, 20850, USA., Schuler M; Pfizer Research, Development, and Medical, Groton, CT, 06370, USA., Chen CL; Health and Environmental Sciences Institute, Washington, DC, 20005, USA., Puglisi R; Health and Environmental Sciences Institute, Washington, DC, 20005, USA. |
